NEOS - Neos Therapeutics Inc
Close
1.15
-0.030 -2.609%
Share volume: 0
Last Updated: Fri 19 Mar 2021 09:00:01 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$1.18
-0.03
-2.54%
Summary score
26%
Profitability
35%
Dept financing
40%
Liquidity
13%
Performance
16%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
39.55%
Return on assets
-10.56%
Return on sales
-214.52%
Return on invested capital
96.2%
Total debt ratio
102.41%
Debt ratio change over timeo
3.22%
Current Ratio
1.76%
Quick Ratio
1.53%
Cash Position Ratio
0.82%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
54.75%
Return on assets
-3.39%
Return on sales
-18.79%
Return on invested capital
11.6%
Total debt ratio
112.66%
Debt ratio change over timeo
11.04%
Current Ratio
0.95%
Quick Ratio
0.78%
Cash Position Ratio
0.32%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
34.06%
Return on assets
-4.59%
Return on sales
-21.89%
Return on invested capital
14.28%
Total debt ratio
125.8%
Debt ratio change over time
6.13%
Current Ratio
0.66%
Quick Ratio
0.52%
Cash Position Ratio
0.21%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-53.26%
Return on assets
-116.57%
Return on sales
-203.64%
Return on invested capital
-49.27%
Total debt ratio
322.34%
Debt ratio change over time
3.22%
Current Ratio
3.15%
Quick Ratio
2.45%
Cash Position Ratio
0.45%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NEOS | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 39.55% | 0% | 0% | 29.06% |
| Return on assets | -10.56% | 0% | 0% | -9.75% |
| Return on sales | -214.52% | 0% | 0% | -1469.44% |
| Return on invested capital | 96.2% | 0% | 0% | 47.78% |
| Profitability | 50% | 0% | 50% | 31% |
| Total debt ratio | 102.41% | 0% | 0% | 183.15% |
| Debt ratio change over time | 3.22% | 0% | 0% | 19.02% |
| Dept financing | 18% | 0% | 0% | 50% |
| Current Ratio | 0.95% | 0% | 0% | 5.9% |
| Quick Ratio | 0.78% | 0% | 0% | 5.9% |
| Cash Position Ratio | 0.32% | 0% | 0% | 5.68% |
| Liquididy | 24% | 0% | 0% | 75% |
| Short-term ratios | NEOS | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 54.75% | 0% | 0% | -16.12% |
| Return on assets | -3.39% | 0% | 0% | -14.95% |
| Return on sales | -18.79% | 0% | 0% | -3498.94% |
| Return on invested capital | 11.6% | 0% | 0% | 96.56% |
| Profitability | 28% | 0% | 50% | 25% |
| Total debt ratio | 112.66% | 0% | 0% | 79.61% |
| Debt ratio change over time | 11.04% | 0% | 0% | 0.09% |
| Dept financing | 50% | 0% | 0% | 18% |
| Current Ratio | 0.95% | 0% | 0% | 5.9% |
| Quick Ratio | 0.78% | 0% | 0% | 5.9% |
| Cash Position Ratio | 0.32% | 0% | 0% | 5.68% |
| Liquididy | 9% | 0% | 0% | 75% |